|
|
|
|
|
|
|
|
|
09.12.25 - 18:45
|
Broadwood Partners Responds to Alcon′s Increase to Proposed Acquisition Price of STAAR Surgical (Business Wire)
|
|
|
Notes That Price Bump Is Further Evidence That the Original Sale Process Was Horribly Flawed and Failed to Maximize Shareholder Value
New Price Is Approximately Half the Price Offered by Alcon Twice in 2024; STAAR's Projections Have Not Changed Materially
Continues to Urge STAAR Shareholders to Vote “AGAINST” the Proposed Transaction
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC).
Broadwood, which owns 30.2% of STAAR's outstanding common stock, continues to oppose the proposed sale of the Company to Alcon and issued the following statement:
“STAAR spent months trying to convince the Company's shareholders that the Board had run a proper sale process and achieved a fair buyout price from Alcon. The Board also claimed tha...
|
|
|
|
|
|
|
|
|
|
|
|
|
09.12.25 - 14:39
|
Alcon Announces Amended Merger Agreement with STAAR Surgical (Business Wire)
|
|
|
Agreement follows discussions with STAAR stockholders and the closure of STAAR's “go-shop” period
New terms include an increase in acquisition price and reductions in payments to executives
Alcon urges STAAR stockholders to vote in favor of the transaction in advance of the December 19, 2025, meeting
GENEVA--(BUSINESS WIRE)--Regulatory News:
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR Surgical Company (NASDAQ: STAA, “STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction.
In November 2025, by mutual agreement with Alcon, the STAAR Board began an unencumbered “go-shop” process, in connection with which Alcon waived its matching rights and any break-up fee if a superior proposal materialized. No such offer was received and the “go-shop” window expired on December 6.
O...
|
|
|
08.12.25 - 19:33
|
Broadwood Partners Reiterates Opposition to STAAR Surgical′s Sale to Alcon Following Conclusion of Performative Go-Shop Process (Business Wire)
|
|
|
Believes Belated Go-Shop Process Fails to Cure Fundamental Flaws in the Transaction's Process, Timing, and Price
Expresses Disappointment that the Self-Interested and Conflicted Board Members Continue to Press Forward with a Transaction that Shareholders Have Already Roundly Rejected
Continues to Urge STAAR Shareholders to Vote “AGAINST” the Proposed Transaction
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us,” or “our”) today issued the following open letter to the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAAR's outstanding common stock, continues to oppose the proposed sale of the Company to Alcon Inc. (“Alcon”) (NYSE: ALC) on transaction terms that remain unchanged following the conclusion of the Company's flawed and belated go-shop process.
The full text of Broadwood's letter is below. Shareholders can find additional information at w...
|
|
|
|
|
08.12.25 - 14:03
|
STAAR Surgical Announces Expiration of Go-Shop Period (Business Wire)
|
|
|
No Competing Acquisition Proposals Received
Results of Go-Shop Process Validate the Effectiveness of the STAAR Board's Process
Now is the Right Time to Sell the Business and Alcon is the Right Buyer
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the previously announced go-shop period pursuant to STAAR's amended merger agreement with Alcon Inc. (SIX/NYSE: ALC). The go-shop period expired at 11:59 p.m. Eastern Time on December 6, 2025. No proposals were received prior to the expiration.
During the go-shop period, STAAR, with the assistance of its financial advisor, Citi, actively solicited acquisition proposals from a wide range of potentially interested third parties. In total, STAAR engaged with 21 third parties, including financial sponsors, potential strategic acquirers and the parties previously identified in STAAR'...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
